OUTLOOK THERAPEUTICS, INC. Cash and Restricted Cash
OUTLOOK THERAPEUTICS, INC. (OTLK) had Cash and Restricted Cash of $11.24 million as of 2026-06-30, per its 10-Q filed 2026-08-18.
Financial Statements › Cash Flow
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-18
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $11.24M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7.75M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8.68M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8.08M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $11.24M 10-Q · filed 2026-08-18 |
| 2026-03-31 | $7.75M 10-Q · filed 2026-05-15 |
| 2025-12-31 | $8.68M 10-Q · filed 2026-02-17 |
| 2025-09-30 | $8.08M 10-Q · filed 2026-08-18 |
| 2025-06-30 | $8.90M 10-Q · filed 2026-08-18 |
| 2025-03-31 | $7.56M 10-Q · filed 2026-05-15 |
| 2024-12-31 | $5.70M 10-Q · filed 2026-02-17 |
| 2024-09-30 | $14.93M 10-Q · filed 2026-08-18 |
| 2024-06-30 | $32.02M 10-Q · filed 2025-08-14 |
| 2024-03-31 | $47.23M 10-Q · filed 2025-05-15 |
| 2023-12-31 | $10.36M 10-Q · filed 2025-02-14 |
| 2023-09-30 | $23.39M 10-K · filed 2025-12-19 |
| 2023-06-30 | $33.71M 10-Q · filed 2024-08-14 |
| 2023-03-31 | $43.63M 10-Q · filed 2024-05-15 |
| 2022-12-31 | $52.34M 10-Q · filed 2024-02-14 |
| 2022-09-30 | $17.40M 10-K · filed 2024-12-27 |
| 2022-06-30 | $26.02M 10-Q · filed 2023-08-14 |
| 2022-03-31 | $58.42M 10-Q · filed 2023-05-15 |
| 2021-12-31 | $70.15M 10-Q · filed 2023-02-14 |
| 2021-09-30 | $14.48M 10-K · filed 2023-12-22 |
| 2021-06-30 | $19.69M 10-Q · filed 2022-08-10 |
| 2021-03-31 | $37.17M 10-Q · filed 2022-05-13 |
| 2020-12-31 | $5.57M 10-Q · filed 2022-02-14 |
| 2020-09-30 | $12.54M 10-K · filed 2022-12-29 |
| 2020-06-30 | $23.95M 10-Q · filed 2021-08-13 |
| 2020-03-31 | $4.65M 10-Q · filed 2021-05-14 |
| 2019-12-31 | $1.33M 10-Q · filed 2021-02-16 |
| 2019-09-30 | $8.02M 10-K · filed 2021-12-23 |
| 2019-06-30 | $14.03M 10-Q · filed 2020-08-14 |
| 2019-03-31 | $155.47K 10-Q · filed 2020-05-15 |
| 2018-12-31 | $227.72K 10-Q · filed 2020-02-14 |
| 2018-09-30 | $1.72M 10-K · filed 2020-12-23 |
| 2017-09-30 | $3.19M 10-K · filed 2019-12-19 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Acumen Pharmaceuticals, Inc. (ABOS) | United States | $0.162B | -1.83 |
| Humacyte, Inc. (HUMA) | United States | $0.155B | -2.26 |
| Voyager Therapeutics, Inc. (VYGR) | United States | $0.173B | -1.99 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| Tenaya Therapeutics, Inc. (TNYA) | United States | $0.140B | -1.60 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Caribou Biosciences, Inc. (CRBU) | United States | $0.134B | -1.79 |
| Armata Pharmaceuticals, Inc. (ARMP) | United States | $0.132B | |
| Neumora Therapeutics, Inc. (NMRA) | United States | $0.132B | -1.48 |